{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T19:13:22Z","timestamp":1775330002156,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009010","name":"Novartis | Novartis Pharmaceuticals UK Limited","doi-asserted-by":"publisher","award":["OAP030A2401T"],"award-info":[{"award-number":["OAP030A2401T"]}],"id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41433-025-04210-5","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T14:17:49Z","timestamp":1768054669000},"page":"493-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early detection of neovascular age-related macular degeneration in the second eye reduces intravitreal treatment burden: FASBAT report 2"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2569-9810","authenticated-orcid":false,"given":"Rachel L. W.","family":"Hanson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Airody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4388-243X","authenticated-orcid":false,"given":"Martin","family":"McKibbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony B.","family":"Morland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-0381","authenticated-orcid":false,"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-3734","authenticated-orcid":false,"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0213-6253","authenticated-orcid":false,"given":"Richard P.","family":"Gale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the FASBAT study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard P.","family":"Gale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"McKibbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Downey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeta","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ben Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep","family":"Bindra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Pagliarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faruque","family":"Ghanchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjiv","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konidaris","family":"Vasileios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Dodds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savita","family":"Madhusudhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Whistance-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"Empeslidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"4210_CR1","unstructured":"NICE. Age-related macular degeneration NICE guidelines. 2018. https:\/\/www.nice.org.uk\/guidance\/ng82\/resources\/agerelated-macular-degeneration-pdf-1837691334853."},{"key":"4210_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/bjophthalmol-2014-306229","volume":"99","author":"AY Lee","year":"2015","unstructured":"Lee AY, Lee CS, Butt T, Xing W, Johnston RL, Chakravarthy U, et al. UK AMD EMR USERS GROUP REPORT V: Benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6\/12. Br J Ophthalmol. 2015;99:1045\u201350.","journal-title":"Br J Ophthalmol"},{"key":"4210_CR3","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.ophtha.2021.07.025","volume":"128","author":"S Sivaprasad","year":"2021","unstructured":"Sivaprasad S, Banister K, Azuro-Blanco A, Goulao B, Cook JA, Hogg R, et al. Diagnostic accuracy of monitoring tests of fellow eyes in patients with unilateral neovascular age-related macular degeneration: early detection of neovascular age-related macular degeneration study. Ophthalmology. 2021;128:1736\u201347. https:\/\/doi.org\/10.1016\/j.ophtha.2021.07.025.","journal-title":"Ophthalmology"},{"key":"4210_CR4","doi-asserted-by":"publisher","unstructured":"Gale RP, Airody A, Sivaprasad S, Hanson RLW, Allgar V, McKibbin M, et al. Improved structure and function in early detected second eye neovascular age-related macular degeneration; FASBAT\/EDNA report 1. Ophthalmol Retina. 2024. https:\/\/doi.org\/10.1016\/j.oret.2023.12.012.","DOI":"10.1016\/j.oret.2023.12.012"},{"key":"4210_CR5","unstructured":"Norridge CFE, Gruszka-Goh MH, Mckibbin M, Henry P, Donachie J. The first report of age-related macular degeneration audit (AMD) patients starting treatment for neovascular AMD. 2023. The Royal College of Ophthalmologists, National Ophthalmology Database Audit. https:\/\/nodaudit.org.uk\/node\/4174."},{"key":"4210_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3928\/23258160-20210302-02","volume":"52","author":"MR Starr","year":"2021","unstructured":"Starr MR, Xu D, Boucher N, Saroj N, Patel LG, Ammar M, et al. Characterizing progression to neovascular amd in fellow eyes of patients treated with intravitreal anti-vegf injections. Ophthalmic Surg Lasers Imaging Retin. 2021;52:123\u20138.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"4210_CR7","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.ophtha.2014.04.026","volume":"121","author":"J Zarranz-Ventura","year":"2014","unstructured":"Zarranz-Ventura J, Liew G, Johnston RL, Xing W, Akerele T, McKibbin M, et al. The neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyes. Ophthalmology. 2014;121:1966\u201375.","journal-title":"Ophthalmology"},{"key":"4210_CR8","unstructured":"Hanson RLW, Airody A, Sivaprasad S, Gale RP. Optical coherence tomography imaging biomarkers associated with neovascular age-related macular degeneration: a systematic review. Eye. 2022. https:\/\/www.nature.com\/articles\/s41433-022-02360-4."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04210-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04210-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04210-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:12:54Z","timestamp":1772521974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04210-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4210"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04210-5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RPG: Received honorarium for advisory board meetings and speaker fees from Abbvie, Allergan, Alimera, Apellis, Bayer, Heidelberg Engineering, Lux Biosciences, Novartis, Notal Vision and Roche; Institutional grants from Novartis Pharmaceuticals UK Ltd and Bayer Pharmaceuticals. SS: Member of the Eye editorial board. Institutional research grants and received support for publication from Novartis, Bayer, Allergan\/Abbvie and Boehringer Ingleheim; Attended advisory board meetings of Allergan, Apellis, Bayer, Boehringer Ingelheim, Heidelberg Engineering, Novartis, Oxurion, Oculis, Optos, Ophthea and Roche. UC: Personal fees from Novartis, Iveric, Roche, Boehringer Ingleheim, Apellis and Alimera; Other: Bayer, Gyroscope. TP: Member of the Eye editorial board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}